Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-06-01
著者
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
OGITA Masami
Sapporo National Hospital
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Suzuki R
Department Of Hsct Data Management Nagoya University Hospital
-
Suzuki Ritsurou
東京大学医学部附属病院 無菌治療部
-
Suzuki Ritsuro
豊橋市民病院 血液･腫瘍内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
MIURA Kazuhisa
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
-
TAKEUCHI Takahiro
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital
-
Takeuchi Takahiro
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takahashi Toshitada
愛知県がんセンター研究所 腫瘍免疫学
-
Taji Hirohumi
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Miura Kazuhisa
Department Of Internal Medicine & Molecular Science Nagoya City University Graduate School Of Me
-
Suzuki Ritsurou
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Takenaka T
National Cancer Center Hospital Tokyo Jpn
-
Tagawa Hiroyuki
Department Of Mathematical Sciences University Of Tokyo
-
Terauchi Takashi
Diagnostic Radiology Divisions National Cancer Center Hospital
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Takeuchi Takahiro
Department Of Cardiology National Hospital Organization Nagano Hospital
-
Miura Kazuhisa
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Taniguchi Hirokazu
Clinical Laboratory Division National Cancer Center Hospital
-
Suzuki Ritsuro
Department Of Hsct Data Management And Biostatistics Nagoya University School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Suzuki Ritsuro
Department Of Hematopoietic Stem Cell Transplantation Data Management School Of Medicine Nagoya Univ
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Suzuki Risturo
Division Of Molecular Medicine Aichi Cancer Center Research Institute
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- High-grade mature B-cell lymphoma with Burkitt-like morphology : Results of a clinicopathological study of 72 Japanese patients
- Rare pancreatic neoplasms : the utility of endoscopic ultrasound-guided fine-needle aspiration : a large single center study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Risk factors for vitamin D deficiency in patients with Crohn's disease
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Mylotarg Is Not a "Magic Bullet"
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Current treatment strategy and new agents in mantle cell lymphoma
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma